← Leaderboards
Hu Li
Mayo Clinic Rochester
$4,987,652
Attributed
$9,128,211
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2016–24$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,128,211 · 5
By mechanism
RF1$4,355,359 · 1
R01$4,132,052 · 2
R03$640,800 · 2
Top collaborators
- Martin Ernesto Fernandez-Zapico5 shared
- Gloria M. Petersen5 shared
- Benjamin L Wolozin2 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Eric D Wieben$6,682,438
- Jan M. Van Deursen$15,959,798
- Shruthi Naik$1,310,428
- Martin Ernesto Fernandez-Zapico$10,185,222
- Nicholas F. Larusso$19,780,617
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesBaseProteinsPhenotypeSignal TransductionData SetMolecularMalignant NeoplasmsLightAlzheimer&AposCellsVariantAlgorithmsPathway InteractionsGene ExpressionDiagnosisMutationGenomeAffectGeneticGenotypeBiologicalEtiologyInnovation
Grant awards (12)
Common Fund Gene Utility Compendium: A Systems Biology Resource to Explore Tissue-Specific Functional Genes and Druggable Genomes$322,800
R03 · FY2024 · OD · contact PI
Uncovering therapeutic-associated biomarkers via machine learning and feature engineering approaches$318,000
R03 · FY2022 · OD · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$590,577
R01 · FY2020 · CA
Capturing the molecular complexity of Alzheimer's disease through the lens of RNA binding proteins$410,947
RF1 · FY2020 · AG
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$583,253
R01 · FY2019 · CA
Capturing the molecular complexity of Alzheimer's disease through the lens of RNA binding proteins$3,944,412
RF1 · FY2018 · AG
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$601,292
R01 · FY2018 · CA
A network platform to connect drug response and prognosis phenotypes for cancers$395,911
R01 · FY2018 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$590,577
R01 · FY2017 · CA
A network platform to connect drug response and prognosis phenotypes for cancers$395,911
R01 · FY2017 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$578,620
R01 · FY2016 · CA
A network platform to connect drug response and prognosis phenotypes for cancers$395,911
R01 · FY2016 · CA · contact PI